Aktive Positionen von Charlie Qi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRANSCENTA HOLDING LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 | - |
| Roche Global Product Development Center | Corporate Officer/Principal | 01.08.2017 | - |
Karriereverlauf von Charlie Qi
Ehemalige bekannte Positionen von Charlie Qi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01.05.2012 | 01.08.2017 |
Statistik
International
| China | 4 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Roche Global Product Development Center | |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Börse
- Insiders
- Charlie Qi
- Erfahrung
